These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2531115)

  • 1. Atrial natriuretic factor in liver cirrhosis--the influence of volume expansion.
    Tesar V; Horký K; Petrýl J; Kozáková M; Gregorová I; Brodanová M; Kordac V; Hirsa M
    Horm Metab Res; 1989 Sep; 21(9):519-22. PubMed ID: 2531115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
    Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
    Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
    Morali GA; Floras JS; Legault L; Tobe S; Skorecki KL; Blendis LM
    Am J Med; 1991 Oct; 91(4):383-92. PubMed ID: 1835288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading].
    Horký K; Tesar V; Gregorová I; Srámková J; Dvoráková J
    Vnitr Lek; 1990 Jul; 36(7):625-32. PubMed ID: 2147304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implications.
    Angeli P; Caregaro L; Menon F; Sacerdoti D; De Toni R; Merkel C; Gatta A
    Hepatology; 1992 Dec; 16(6):1389-94. PubMed ID: 1446894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: circadian study.
    Colantonio D; Pasqualetti P; Casale R; Desiati P; Giandomenico G; Natali G
    Life Sci; 1989; 45(7):631-5. PubMed ID: 2528047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis].
    Tesar V; Petrtýl J; Jedlicka J; Horký K; Gregorová I; Kopecká J; Marek J; Marecek Z; Kordac V
    Cas Lek Cesk; 1990 Apr; 129(17):520-5. PubMed ID: 2140956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: basal levels, changes during daily activity and nocturnal diuresis.
    Panos MZ; Anderson JV; Payne N; Langley P; Slater JD; Rees L; Williams R
    Hepatology; 1992 Jul; 16(1):82-8. PubMed ID: 1535609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
    Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
    Gentile S; Bologna E; Terracina D; Angelico M
    Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B; Jensen L; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
    Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of urodilatin in patients with cirrhosis.
    Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
    Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurohumoral activity in liver cirrhosis].
    Lazúrová I; Rosochová I; Lichardus B; Trejbal D; Hildebrand T; Tkác I; Machánová Y; Murár J
    Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
    Colantonio D; Casale R; Pasqualetti P
    Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
    J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.